Pfizer Inc
PFE
Company Profile
Business description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Contact
66 Hudson Boulevard East
New YorkNY10001-2192
USAT: +1 212 733-2323
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
75,000
Stocks News & Analysis
stocks
ASX share undervalued despite margin woes
Short term margin pressure yet shares remain undervalued on improved outlook.
stocks
A better way to predict long-term stock returns
A value-weighted version of the CAPE ratio corrects a structural flaw and delivers stronger forecasts of long-term stock returns.
stocks
Five star stock added to August best ideas list
Morningstar analysts hand pick this undervalued opportunity for their August global best ideas.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,849.30 | 74.60 | -0.84% |
| CAC 40 | 8,090.28 | 27.50 | -0.34% |
| DAX 40 | 25,402.28 | 38.53 | -0.15% |
| Dow JONES (US) | 52,055.18 | 366.02 | -0.70% |
| FTSE 100 | 10,658.13 | 39.44 | -0.37% |
| HKSE | 24,667.24 | 250.36 | -1.00% |
| NASDAQ | 25,970.73 | 215.69 | -0.82% |
| Nikkei 225 | 63,484.10 | 8.89 | -0.01% |
| NZX 50 Index | 13,484.22 | 76.47 | -0.56% |
| S&P 500 | 7,582.73 | 37.25 | -0.49% |
| S&P/ASX 200 | 8,672.50 | 77.40 | -0.88% |
| SSE Composite Index | 3,864.28 | 21.05 | -0.54% |